NO20004412D0 - HIV regulatoriske og hjelpepeptider, antigener, vaksine, blandinger, immunoassay, kit og en fremgangsmÕte for pÕvisning av antistoffer som blir infusert av HIV - Google Patents

HIV regulatoriske og hjelpepeptider, antigener, vaksine, blandinger, immunoassay, kit og en fremgangsmÕte for pÕvisning av antistoffer som blir infusert av HIV

Info

Publication number
NO20004412D0
NO20004412D0 NO20004412A NO20004412A NO20004412D0 NO 20004412 D0 NO20004412 D0 NO 20004412D0 NO 20004412 A NO20004412 A NO 20004412A NO 20004412 A NO20004412 A NO 20004412A NO 20004412 D0 NO20004412 D0 NO 20004412D0
Authority
NO
Norway
Prior art keywords
hiv
immunoassays
infused
vaccines
antigens
Prior art date
Application number
NO20004412A
Other languages
English (en)
Other versions
NO314587B1 (no
NO20004412L (no
Inventor
Birger Soerensen
Original Assignee
Bionor As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionor As filed Critical Bionor As
Priority to NO20004412A priority Critical patent/NO314587B1/no
Publication of NO20004412D0 publication Critical patent/NO20004412D0/no
Priority to EA200300335A priority patent/EA006210B1/ru
Priority to EP01965768A priority patent/EP1322666B1/en
Priority to CN200910140941A priority patent/CN101628933A/zh
Priority to JP2002525175A priority patent/JP2004508382A/ja
Priority to AT01965768T priority patent/ATE378350T1/de
Priority to PCT/NO2001/000363 priority patent/WO2002020555A2/en
Priority to AU2001286336A priority patent/AU2001286336B2/en
Priority to CN01815739A priority patent/CN1458936A/zh
Priority to SK401-2003A priority patent/SK287913B6/sk
Priority to AU8633601A priority patent/AU8633601A/xx
Priority to NZ535908A priority patent/NZ535908A/xx
Priority to HU0303132A priority patent/HUP0303132A3/hu
Priority to BR0114046-9A priority patent/BR0114046A/pt
Priority to CA002421199A priority patent/CA2421199A1/en
Priority to NZ524557A priority patent/NZ524557A/en
Priority to US10/129,333 priority patent/US7097971B2/en
Priority to DE60131432T priority patent/DE60131432T2/de
Priority to ES01965768T priority patent/ES2296793T3/es
Priority to ARP010104195A priority patent/AR033997A1/es
Publication of NO20004412L publication Critical patent/NO20004412L/no
Priority to ZA200301742A priority patent/ZA200301742B/en
Publication of NO314587B1 publication Critical patent/NO314587B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20004412A 2000-09-04 2000-09-04 HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV NO314587B1 (no)

Priority Applications (21)

Application Number Priority Date Filing Date Title
NO20004412A NO314587B1 (no) 2000-09-04 2000-09-04 HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV
ES01965768T ES2296793T3 (es) 2000-09-04 2001-09-03 Peptidos de vih de regiones conservadas, tat, rev y wef y su aplicacion como por ejemplo componentes de vacuna.
AU8633601A AU8633601A (en) 2000-09-04 2001-09-03 Hiv regulatory and auxiliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv
HU0303132A HUP0303132A3 (en) 2000-09-04 2001-09-03 Hiv regulatory and auxiliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv
CN200910140941A CN101628933A (zh) 2000-09-04 2001-09-03 来自Tat、Rev和Nef保守区的HIV肽以及它们作为例如疫苗组分的应用
JP2002525175A JP2004508382A (ja) 2000-09-04 2001-09-03 Ｈｉｖ調節及び補助ペプチド、抗原、ワクチン組成物、ｈｉｖにより誘発される抗体を検出するためのイムノアッセイキット及び方法
AT01965768T ATE378350T1 (de) 2000-09-04 2001-09-03 Hiv-peptide aus tat-, rev- und wef-konservierten regionen und deren anwendung z.b. als impfstoffkomponenten
PCT/NO2001/000363 WO2002020555A2 (en) 2000-09-04 2001-09-03 Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components
AU2001286336A AU2001286336B2 (en) 2000-09-04 2001-09-03 HIV peptides from Tat, Rev and Wef conserved and their application as E.G. vaccine components
CN01815739A CN1458936A (zh) 2000-09-04 2001-09-03 来自Tat、Rev和Nef保守区的HIV肽以及它们作为例如疫苗组分的应用
SK401-2003A SK287913B6 (sk) 2000-09-04 2001-09-03 Peptide derived from HIV-1 regulatory protein, antigens and use thereof, vaccine composition, method of detecting antibodies induced by HIV, immunoassay kit, antibody and plasmid DNA
EA200300335A EA006210B1 (ru) 2000-09-04 2001-09-03 Регуляторные и вспомогательные пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
NZ535908A NZ535908A (en) 2000-09-04 2001-09-03 HIV regulatory and auxilliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
EP01965768A EP1322666B1 (en) 2000-09-04 2001-09-03 Hiv peptides from tat,rev and wef conserved regions and their application as e.gvacine compnents
BR0114046-9A BR0114046A (pt) 2000-09-04 2001-09-03 Peptìdeos reguladores e auxiliares de hiv, antìgenos, composições de vacinas, kit de imunoensaio e um método para detectar anticorpos induzidos por hiv
CA002421199A CA2421199A1 (en) 2000-09-04 2001-09-03 Hiv regulatory and auxiliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv
NZ524557A NZ524557A (en) 2000-09-04 2001-09-03 HIV regulatory and auxiliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
US10/129,333 US7097971B2 (en) 2000-09-04 2001-09-03 HIV-1 peptide, antigen, immunogenic composition, diagnostic method and immunoassay kit
DE60131432T DE60131432T2 (de) 2000-09-04 2001-09-03 Hiv-peptide aus tat-, rev- und wef-konservierten regionen und deren anwendung z.b. als impfstoffkomponenten
ARP010104195A AR033997A1 (es) 2000-09-04 2001-09-04 Peptidos regulatorios y auxiliares de vih, antigenos, composiciones de vacunas, kit de inmunoensayo y un metodo para detectar anticuerpos inducidos por vih
ZA200301742A ZA200301742B (en) 2000-09-04 2003-03-03 HIV peptides from tat, rev and nef conserved regions and their application as e.g. vaccine components.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20004412A NO314587B1 (no) 2000-09-04 2000-09-04 HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV

Publications (3)

Publication Number Publication Date
NO20004412D0 true NO20004412D0 (no) 2000-09-04
NO20004412L NO20004412L (no) 2002-03-05
NO314587B1 NO314587B1 (no) 2003-04-14

Family

ID=19911532

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004412A NO314587B1 (no) 2000-09-04 2000-09-04 HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV

Country Status (18)

Country Link
US (1) US7097971B2 (no)
EP (1) EP1322666B1 (no)
JP (1) JP2004508382A (no)
CN (2) CN101628933A (no)
AR (1) AR033997A1 (no)
AT (1) ATE378350T1 (no)
AU (2) AU2001286336B2 (no)
BR (1) BR0114046A (no)
CA (1) CA2421199A1 (no)
DE (1) DE60131432T2 (no)
EA (1) EA006210B1 (no)
ES (1) ES2296793T3 (no)
HU (1) HUP0303132A3 (no)
NO (1) NO314587B1 (no)
NZ (2) NZ535908A (no)
SK (1) SK287913B6 (no)
WO (1) WO2002020555A2 (no)
ZA (1) ZA200301742B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004503205A (ja) 2000-02-04 2004-02-05 デューク・ユニバーシティー ヒト免疫不全ウイルスワクチン
ES2616341T3 (es) 2006-03-10 2017-06-12 Peptcell Limited Péptidos de proteínas reguladoras o accesorias de VIH, composiciones y la utilización de las mismas
JP4931483B2 (ja) * 2006-06-14 2012-05-16 ルネサスエレクトロニクス株式会社 半導体不良解析装置、不良解析方法、及び不良解析プログラム
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
CN102210874A (zh) * 2011-05-17 2011-10-12 浙江大学 一种hiv重组亚型dna疫苗的制备方法
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
IN2014KN02769A (no) * 2012-06-06 2015-05-08 Bionor Immuno As
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
RU2653754C2 (ru) * 2012-12-06 2018-05-14 Пин Фарма, Инк. Лечение воспалительных, аутоиммунных и нейродегенеративных нарушений иммуннодепрессивными полипетидами, являющимися производными тат
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219990A (en) * 1991-01-28 1993-06-15 Biogen, Inc. Papillomavirus e2 trans-activation repressors
WO1994015634A1 (en) 1992-12-30 1994-07-21 Matthias Rath Tat and rev oligopeptides in hiv treatment
ATE196255T1 (de) 1995-03-08 2000-09-15 Neovacs Von einem retroviralen regulationsprotein abstammende, detoxifierte immunogene, dagegen gerichtete antikörper, verfahren zur deren herstellung und diese immunogene oder antikörper enthaltende, pharmazeutische zusammensetzungen.
US5891994A (en) * 1997-07-11 1999-04-06 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
IT1297090B1 (it) 1997-12-01 1999-08-03 Barbara Ensoli Tat di hiv-1 o suoi derivati, da soli od in combinazione, a scopo vaccinale, profilattico e terapeutico, contro l'aids i tumori e le
FR2773156B1 (fr) * 1997-12-26 2000-03-31 Biovacs Inc Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
NO311807B1 (no) 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
AU4082300A (en) 1999-06-21 2001-01-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Hiv tat peptides and multiple peptide conjugate system
SE0001351L (sv) * 2000-04-12 2001-03-26 Kjell Sjoegren Smådjurstoalett

Also Published As

Publication number Publication date
ZA200301742B (en) 2004-06-21
WO2002020555A2 (en) 2002-03-14
NZ535908A (en) 2006-03-31
ES2296793T3 (es) 2008-05-01
SK4012003A3 (en) 2003-09-11
US20050053616A1 (en) 2005-03-10
NZ524557A (en) 2005-04-29
AR033997A1 (es) 2004-01-21
BR0114046A (pt) 2003-07-22
DE60131432D1 (de) 2007-12-27
US7097971B2 (en) 2006-08-29
DE60131432T2 (de) 2008-09-18
CA2421199A1 (en) 2002-03-14
EP1322666A2 (en) 2003-07-02
CN101628933A (zh) 2010-01-20
EP1322666B1 (en) 2007-11-14
EA006210B1 (ru) 2005-10-27
HUP0303132A2 (hu) 2005-03-29
EA200300335A1 (ru) 2003-08-28
JP2004508382A (ja) 2004-03-18
NO314587B1 (no) 2003-04-14
HUP0303132A3 (en) 2012-09-28
AU8633601A (en) 2002-03-22
SK287913B6 (sk) 2012-03-02
NO20004412L (no) 2002-03-05
CN1458936A (zh) 2003-11-26
AU2001286336B2 (en) 2007-03-15
WO2002020555A3 (en) 2002-06-06
ATE378350T1 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
NO20004413D0 (no) HIV peptider, antigener, vaksine, blandinger, immunoassay, kit og en fremgangmÕte for pÕvisning av antistoffer som blir infusert av HIV
NO20004412D0 (no) HIV regulatoriske og hjelpepeptider, antigener, vaksine, blandinger, immunoassay, kit og en fremgangsmÕte for pÕvisning av antistoffer som blir infusert av HIV
CY1106820T1 (el) Ανοσοδοκιμασιες για αντι-hcv αντισωματα
IL88248A (en) Solid phase immunoassay for detecting hiv antigens using kc-57 monoclonal antibody, and kit for the performance thereof
MXPA01012662A (es) Deteccion temprana de flavivirus que utiliza la glicoproteina ns1.
EP1139101A3 (en) Immunoassay for c-reactive protein
NO20032549L (no) Humaniserte antistoffer som gjenkjenner beta-amyloid-peptid
NO169844C (no) Htlv-iii (env)-peptider
WO2004025248A3 (en) Antibody pair screening methods
DK1504266T3 (da) Fremgangsmåde til samtidig detektering af en infekteret mikroorganismes antigen og antistof
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
WO1993001210A3 (de) Hcv peptidantigene und verfahren zur bestimmung von hcv
EP1519192A3 (en) Hiv protease inhibitor conjugates and antibodies useful in immunoassay
WO2003006506A3 (en) Protease inhibitor conjugates and antibodies useful in immunoassay
EP1072888A3 (en) Immunoassay method and reagent for HIV-1p24 antigen
AU4475285A (en) Immunoassay for detection of common determinant antibody to hepatitis B
AU2001288431A1 (en) Detection of anti-glycolipid antibodies by latex agglutination assay
WO2004021871A3 (en) Hcv assay
EP1700122A4 (en) IMMUNOASSAYS, HAPTENE, IMMUNOGENES AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS
DE69717991D1 (de) Ein monoklonaler antikörper, welcher ein apoptotisches antigen nachweist
AU2002215215A1 (en) Antibody against norwalk virus and method of detecting virus by using the antibody
AU2004200155B2 (en) HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
DE69228720D1 (de) Liposome-Immunoassay zum Nachweis von Antigenen, Antikörpern und Haptenen
ITPD20000192A0 (it) Anticorpi policlonali
EP1829891A3 (en) Immunoassays for Anti-HCV Antibodies

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees